Showing results (141-150 of 667) with videos related to

Sort By:
Pageof 67
Hemasphere|July 8, 2026
Inflammatory signatures in the spectrum of myeloid diseasesAlice Ibbotson, Simon Crouch, Jacqueline Ferrari, et al.
Hemasphere|April 30, 2026
A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient miceQuentin Kimmerlin, Morgane Hilpert, Nils Hansen, et al.
Hemasphere|April 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myelomaChrissy Baker, Elizabeth Hill, Dickran Kazandjian, et al.
Hemasphere|April 6, 2026
Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanismsAntonia Mikulova, Hana Plesingerova, Michaela Chorvatova, et al.
Hemasphere|April 16, 2026
Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone lossManja Wobus, Heike Weidner, Rebekka Wehner, et al.
Hemasphere|May 8, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA groupPierre Sesques, Guillaume Manson, Guillaume Cartron, et al.
Hemasphere|August 12, 2026
Venetoclax plus azacitidine, low-dose cytarabine, aclarubicin, and G-CSF (VA-CAG regimen) for newly diagnosed young patients with acute myeloid leukemia: A prospective, multicenter, single-arm Phase II clinical trialXiaoping Li, Qiurong Zhang, Xiaoyan Li, et al.
Hemasphere|September 18, 2026
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclaxJohanne U Hermansen, Weikaixin Kong, Andrea M Brodersen, et al.
Hemasphere|September 13, 2026
Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathiesDavid F Moreno, Ferran Nadeu, Marta Casado-Peláez, et al.
Hemasphere|September 15, 2026
The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groupsThomas Beder, Nadine Wolgast, Wencke Walter, et al.
Pageof 67